Dallas, TXNCT07808073Now EnrollingIRB Ready

Obesity Clinical Trial in Dallas, TX

Access cutting-edge obesity treatment through this phase 1 clinical trial at a research site in Dallas. Study-provided care at no cost to qualified participants.

Sponsored by Eli Lilly and Company

Quick Self-Assessment

See if you qualify for this Dallas location

Preparing your pre-screening questions…

Expert Care in Dallas

Access obesity specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related obesity treatment provided free

Apply for This Dallas Location

Check if you qualify for this obesity clinical trial in Dallas, TX

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Dallas

    Convenient for TX residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Dallas site if eligible
  4. 4Begin participation

About This Obesity Study in Dallas

The main purpose of this study is to assess how well LY4329090 is tolerated and what side effects may occur in healthy participants with obesity or overweight. Blood tests will be performed to investigate how the body processes the study drug and how the study drug affects the body. Study participants will be in one of 2 parts. For each participant in Part A, the study will last about 10 weeks and will include a stay in the Clinical Research Unit (CRU) lasting 5 nights along with 5 outpatient visits to the CRU. For each participant in Part B, the study will last about 21 weeks and will include 4 stays totaling 11 nights along with 14 outpatient visits to the CRU.

Sponsor: Eli Lilly and Company

Who Can Participate

Inclusion Criteria

Participant must be 18 (21 for Singapore site) to 65 years of age, inclusive, at the time of signing the informed consent.
Are overtly healthy with no comorbidities related to body mass index (BMI).
Have a BMI between 27.0 kilograms per square meter (kg/m²) and 40.0 kg/m², inclusive.
Have had a self-reported stable weight for 3 months prior to screening.

Exclusion Criteria

Have a history or presence of cardiovascular, respiratory, hepatic, renal, gastrointestinal (GI), endocrine, hematological, or neurological disorders.
Have a history of chronic medical conditions involving the heart, liver, or kidneys.
Have either
ongoing asymptomatic bradycardia defined as less than 50 beats per minute at screening visit
electrocardiogram (ECG) findings at screening visit of second-degree atrioventricular block or higher, or
history of symptomatic bradycardia with uncorrected etiology, including diagnosis of sick sinus syndrome.
Have an abnormal blood pressure and/or pulse rate at screening.
Have an obesity induced by other endocrinologic disorders or diagnosed monogenetic or syndromic forms of obesity.
Have any of the following:
a diagnosis of hypocalcemia or hypercalcemia, or
confirmed abnormal laboratory values for calcium and serum phosphorus.
Have a known, clinically significant gastric emptying abnormality, have undergone weight loss surgery, or have had endoscopic and/or device-based therapy for obesity or have had device removal within the last 6 months.
Have been diagnosed with type 1 or type 2 diabetes mellitus or have glycated hemoglobin A1c (HbA1c) greater than or equal to (≥) 6.5 percent (%) or 48 millimoles per mole (mmol/mol) at screening.
Have a history or presence of psychiatric disorders, within the last 2 years, that would present a safety risk or may significantly impair the participant's ability to comply with study procedures.
Have taken any glucose-lowering medications, including insulin, in the past 3 months before screening.
Have received any drugs from the incretins class within 90 days prior to screening.
Have been treated within 3 months prior to screening or plan to be treated with prescription medications that promote weight loss.
Intend to use any weight loss medications during study participation.
Prior (within 6 months) or planned (during the study) device-based treatment use for obesity.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Dallas?

Yes, this clinical trial (NCT07808073) has an active research site in Dallas, TX that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Obesity Treatment Options in Dallas, TX

If you're searching for obesity treatment options in Dallas, TX, this clinical trial (NCT07808073) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Dallas research site is actively enrolling participants for this phase 1 clinical trial. You'll receive care from experienced obesity specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all obesity clinical trials near you to find additional studies recruiting in your area.

More Obesity Trials in Dallas, TX

See all obesity clinical trials recruiting in Dallas — not just this study.

Browse Obesity Trials in Dallas →

Browse More Trials by Condition

Obesity TrialsPediatric Obesity TrialsObesity Hypoventilation Syndrome TrialsAll Conditions →

Ready to Join in Dallas?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Dallas, TX